148 related articles for article (PubMed ID: 15621733)
21. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
Li YF; Deng ZK; Xuan HB; Zhu JB; Ding BH; Liu XN; Chen BA
Chin Med J (Engl); 2009 Jun; 122(12):1413-7. PubMed ID: 19567163
[TBL] [Abstract][Full Text] [Related]
22. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
[TBL] [Abstract][Full Text] [Related]
23. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
Tong H; Ren Y; Zhang F; Jin J
Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
[TBL] [Abstract][Full Text] [Related]
24. Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.
Tang J; Liu Y; Chen J; Xue H; Pan C; Gu L
Int J Hematol; 2011 May; 93(5):610-617. PubMed ID: 21509439
[TBL] [Abstract][Full Text] [Related]
25. A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells.
Zhou X; Xu N; Li R; Xiao Y; Gao G; Lu Q; Ding L; Li L; Li Y; Du Q; Liu X
Leuk Lymphoma; 2015 Jul; 56(7):2162-9. PubMed ID: 25330443
[TBL] [Abstract][Full Text] [Related]
26. Omacetaxine mepesuccinate for the treatment of leukemia.
Kim TD; Frick M; le Coutre P
Expert Opin Pharmacother; 2011 Oct; 12(15):2381-92. PubMed ID: 21916787
[TBL] [Abstract][Full Text] [Related]
27. Homoharringtonine-induced hyperglycemia.
Sylvester RK; Lobell M; Ogden W; Stewart JA
J Clin Oncol; 1989 Mar; 7(3):392-5. PubMed ID: 2645387
[TBL] [Abstract][Full Text] [Related]
28. A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia.
Chen R; Gandhi V; Plunkett W
Cancer Res; 2006 Nov; 66(22):10959-66. PubMed ID: 17108134
[TBL] [Abstract][Full Text] [Related]
29. Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia.
Zhang T; Shen S; Zhu Z; Lu S; Yin X; Zheng J; Jin J
Br J Pharmacol; 2016 Jan; 173(1):212-21. PubMed ID: 26448459
[TBL] [Abstract][Full Text] [Related]
30. Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors.
Cao H; Cheng Y; You L; Qian J; Qian W
Mol Med Rep; 2013 Jun; 7(6):1838-44. PubMed ID: 23620163
[TBL] [Abstract][Full Text] [Related]
31. Homoharringtonine: an effective new natural product in cancer chemotherapy.
Zhou DC; Zittoun R; Marie JP
Bull Cancer; 1995 Dec; 82(12):987-95. PubMed ID: 8745664
[TBL] [Abstract][Full Text] [Related]
32. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
33. Homoharringtonine is an effective therapy for patients with polycythemia vera or essential thrombocythemia who have failed or were intolerant to hydroxycarbamide or interferon-α therapy.
Li Y; Zhu J; Ding B
Int J Clin Oncol; 2013 Oct; 18(5):922-6. PubMed ID: 22898909
[TBL] [Abstract][Full Text] [Related]
34. Omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.
Narayanan V; Gutman JA; Pollyea DA; Jimeno A
Drugs Today (Barc); 2013 Jul; 49(7):447-56. PubMed ID: 23914353
[TBL] [Abstract][Full Text] [Related]
35. Omacetaxine (Synribo) for CML.
Med Lett Drugs Ther; 2015 May; 57(1469):e80-1. PubMed ID: 26039555
[No Abstract] [Full Text] [Related]
36. Homoharringtonine production by endophytic fungus isolated from Cephalotaxus hainanensis Li.
Hu X; Li W; Yuan M; Li C; Liu S; Jiang C; Wu Y; Cai K; Liu Y
World J Microbiol Biotechnol; 2016 Jul; 32(7):110. PubMed ID: 27263005
[TBL] [Abstract][Full Text] [Related]
37. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
Fei J; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
[TBL] [Abstract][Full Text] [Related]
38. [Induction of apoptosis by harringtonine and homoharringtonine in HL-60 cells].
Li L; Xia LJ; Jiang C; Han R
Yao Xue Xue Bao; 1994; 29(9):667-72. PubMed ID: 7900538
[TBL] [Abstract][Full Text] [Related]
39. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
Yin S; Wang R; Zhou F; Zhang H; Jing Y
Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
[TBL] [Abstract][Full Text] [Related]
40. [Cytotoxicity of homoharringtonine on leukemic stem-like cells in AML cell line KG-1].
Shen JP; Yang H; Ni WM; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):485-90. PubMed ID: 23086639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
